the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Market Research Report

UK Private Medical Insurance 2009

Published by Datamonitor Contact us : +1-860-674-8796
Published 2009/05 Content info 63 pages
Product code DC90334
Price From  US $ 4495 Order/Price list
US $ 4495 PDF by E-mail (Single User License)
US $ 11238 PDF by E-mail (Global Site License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Abstract

Introduction

This report gives a comprehensive analysis of the UK private medical insurance sector. An exclusive survey of over 3,500 consumers provides insight into buyer behavior. The report also assesses the current market issues including the potential for cancer top-up policies and the recession and includes data on market size, structure, distribution channels and market shares.

Scope of this research

  • Consumer research on methods of arrangement and future buyer interest based on an exclusive survey of over 3,500 consumers.
  • Insight into the effects of the recession and the potential for cancer top-up policies.
  • Data on the market share of the top groups as well as an analysis of the marketing spend of the top brands.
  • Forecasts of the future size of the market, subscriber numbers and the drivers that will affect the market going forward.

Research and analysis highlights

One of the issues currently affecting the PMI market is the recession. The UK officially entered a recession in the second half of 2008, with two successive quarters of negative GDP growth and there has been a lot of speculation as to how severely this will affect the PMI market.

In November 2008 the government announced that NHS patients would be allowed to pay privately for additional drugs without losing access to NHS care. This could open up a new revenue stream for insurers. The ruling opens up the opportunity for PMI insurers to offer insurance for cancer drugs without the policyholder losing access to NHS care.

Datamonitor expects to see slow growth in the size of the health insurance market in 2009 and 2010 due to lower retention rates and less new business in light of the economic situation. Thereafter, as the economy picks up, Datamonitor forecasts that the PMI market will see steadier growth, with GEP increasing by between 4% and 5% annually.

Key reasons to purchase this research

  • Understand which of your competitors pose the greatest threat, which competitors are gaining market share and which are losing market share.
  • Assess penetration rates, future buyer interest and the most effective distribution channels.
  • Gain insight into the future direction of the sector, including market size and subscriber numbers and the major issues affecting the market.
Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.